Interview: Data And Connected Insight In Arthroplasty Will Take Corin Beyond COVID
Private UK orthopedic company has its own take on innovation that creates health care value
Corin has transformed from a niche UK hip resurfacing company into an innovative global player in orthopedics with a portfolio that includes robotics. UK managing director Paul Gibbons explained the group’s approach to business during COVID-19, and its culture of innovation.
You may also be interested in...
The much-anticipated return to a “normal” NHS service delivery could yet be dashed by a resurgence of the virus.
The findings of the Cumberlege Review into how safety issues for three medical product groups were handled will shape debate on the UK’s new devices legislation, now going through parliament. The MHRA’s devices regulatory activity also comes in for scrutiny.
COVID-19 led to a significant reduction in elective procedures carried out by the UK NHS, broke referral pathways, and put a virtual halt to diagnostics and screening programs. The likely next stages and the concerns of the medtech sector are top priorities for the ABHI.